167 related articles for article (PubMed ID: 19332194)
1. Thrombolysis in Myocardial Infarction (TIMI) Risk Index predicts long-term mortality and heart failure in patients with ST-elevation myocardial infarction in the TIMI 2 clinical trial.
Truong QA; Cannon CP; Zakai NA; Rogers IS; Giugliano RP; Wiviott SD; McCabe CH; Morrow DA; Braunwald E
Am Heart J; 2009 Apr; 157(4):673-9.e1. PubMed ID: 19332194
[TBL] [Abstract][Full Text] [Related]
2. Validated risk score predicts the development of congestive heart failure after presentation with unstable angina or non-ST-elevation myocardial infarction: results from OPUS-TIMI 16 and TACTICS-TIMI 18.
Wylie JV; Murphy SA; Morrow DA; de Lemos JA; Antman EM; Cannon CP
Am Heart J; 2004 Jul; 148(1):173-80. PubMed ID: 15215808
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of serum unbound free fatty acid levels to predict death early in patients with ST-segment elevation myocardial infarction (from the Thrombolysis In Myocardial Infarction [TIMI] II trial).
Huber AH; Kampf JP; Kwan T; Zhu B; Adams J; Kleinfeld AM
Am J Cardiol; 2014 Jan; 113(2):279-84. PubMed ID: 24176067
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of the Thrombolysis in Myocardial Infarction Risk Score in ST-Elevation Myocardial Infarction Patients With Left Ventricular Dysfunction (from the EPHESUS Trial).
Popovic B; Girerd N; Rossignol P; Agrinier N; Camenzind E; Fay R; Pitt B; Zannad F
Am J Cardiol; 2016 Nov; 118(10):1442-1447. PubMed ID: 27677387
[TBL] [Abstract][Full Text] [Related]
5. Association of non-steroidal anti-inflammatory drugs with outcomes in patients with ST-segment elevation myocardial infarction treated with fibrinolytic therapy: an ExTRACT-TIMI 25 analysis.
Gibson CM; Pride YB; Aylward PE; Col JJ; Goodman SG; Gulba D; Bergovec M; Kunadian V; Zorkun C; Buros JL; Murphy SA; Antman EM
J Thromb Thrombolysis; 2009 Jan; 27(1):11-7. PubMed ID: 18695943
[TBL] [Abstract][Full Text] [Related]
6. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making.
Antman EM; Cohen M; Bernink PJ; McCabe CH; Horacek T; Papuchis G; Mautner B; Corbalan R; Radley D; Braunwald E
JAMA; 2000 Aug; 284(7):835-42. PubMed ID: 10938172
[TBL] [Abstract][Full Text] [Related]
7. TIMI risk index and the benefit of enoxaparin in patients with ST-elevation myocardial infarction.
Ruff CT; Wiviott SD; Morrow DA; Mohanavelu S; Murphy SA; Antman EM; Braunwald E;
Am J Med; 2007 Nov; 120(11):993-8. PubMed ID: 17976428
[TBL] [Abstract][Full Text] [Related]
8. Improved in-hospital outcomes in acute coronary syndromes (unstable angina/non-ST segment elevation myocardial infarction) despite similar TIMI risk scores.
Almeda FQ; Hendel RC; Nathan S; Meyer PM; Calvin JE; Klein LW
J Invasive Cardiol; 2003 Sep; 15(9):502-6. PubMed ID: 12947210
[TBL] [Abstract][Full Text] [Related]
9. Extent of ST-segment resolution after fibrinolysis adds improved risk stratification to clinical risk score for ST-segment elevation myocardial infarction.
Harkness JR; Sabatine MS; Braunwald E; Morrow DA; Sloan S; Wiviott SD; Giugliano RP; Antman EM; Cannon CP; Scirica BM
Am Heart J; 2010 Jan; 159(1):55-62. PubMed ID: 20102867
[TBL] [Abstract][Full Text] [Related]
10. TIMI Risk Score accurately predicts risk of death in 30-day and one-year follow-up in STEMI patients treated with primary percutaneous coronary interventions.
Kozieradzka A; Kamiński K; Dobrzycki S; Nowak K; Musiał W
Kardiol Pol; 2007 Jul; 65(7):788-95; discussion 796-7. PubMed ID: 17694460
[TBL] [Abstract][Full Text] [Related]
11. Long-Term clinical outcomes according to initial management and thrombolysis in myocardial infarction risk score in patients with acute non-ST-segment elevation myocardial infarction.
Jeong HC; Ahn Y; Jeong MH; Chae SC; Hur SH; Hong TJ; Kim YJ; Seong IW; Chae JK; Rhew JY; Chae IH; Cho MC; Bae JH; Rha SW; Kim CJ; Choi D; Jang YS; Yoon J; Chung WS; Cho JG; Seung KB; Park SJ;
Yonsei Med J; 2010 Jan; 51(1):58-68. PubMed ID: 20046515
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Ticagrelor Over Time in Patients With Prior MI in PEGASUS-TIMI 54.
Bonaca MP; Storey RF; Theroux P; Steg PG; Bhatt DL; Cohen MC; Im K; Murphy SA; Magnani G; Ophuis TO; Rudah M; Parkhomenko A; Isaza D; Kamensky G; Goudev A; Montalescot G; Jensen EC; Johanson P; Braunwald E; Sabatine MS
J Am Coll Cardiol; 2017 Sep; 70(11):1368-1375. PubMed ID: 28882235
[TBL] [Abstract][Full Text] [Related]
13. The predictive role of modified TIMI risk index in patients with ST-segment elevation myocardial infarction.
Kaya A; Keskin M; Güvenç TS; Tatlısu MA; Kayapınar O
Acta Cardiol; 2019 Feb; 74(1):29-36. PubMed ID: 29475415
[TBL] [Abstract][Full Text] [Related]
14. ST-segment-elevation myocardial infarction patients randomized to a pharmaco-invasive strategy or primary percutaneous coronary intervention: Strategic Reperfusion Early After Myocardial Infarction (STREAM) 1-year mortality follow-up.
Sinnaeve PR; Armstrong PW; Gershlick AH; Goldstein P; Wilcox R; Lambert Y; Danays T; Soulat L; Halvorsen S; Ortiz FR; Vandenberghe K; Regelin A; Bluhmki E; Bogaerts K; Van de Werf F;
Circulation; 2014 Sep; 130(14):1139-45. PubMed ID: 25161043
[TBL] [Abstract][Full Text] [Related]
15. Relation between thrombolysis in myocardial infarction risk score and one-year outcomes for patients presenting at the emergency department with potential acute coronary syndrome.
Weisenthal BM; Chang AM; Walsh KM; Collin MJ; Shofer FS; Hollander JE
Am J Cardiol; 2010 Feb; 105(4):441-4. PubMed ID: 20152236
[TBL] [Abstract][Full Text] [Related]
16. Prasugrel versus clopidogrel in patients with ST-segment elevation myocardial infarction according to timing of percutaneous coronary intervention: a TRITON-TIMI 38 subgroup analysis (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis In Myocardial Infarction 38).
Udell JA; Braunwald E; Antman EM; Murphy SA; Montalescot G; Wiviott SD
JACC Cardiovasc Interv; 2014 Jun; 7(6):604-12. PubMed ID: 24947719
[TBL] [Abstract][Full Text] [Related]
17. Comparison of GRACE and TIMI risk scores in the prediction of in-hospital and long-term outcomes among East Asian non-ST-elevation myocardial infarction patients.
Yanqiao L; Shen L; Yutong M; Linghong S; Ben H
BMC Cardiovasc Disord; 2022 Jan; 22(1):4. PubMed ID: 34996365
[TBL] [Abstract][Full Text] [Related]
18. Prospective validation of a composite end point in thrombolytic trials of acute myocardial infarction (TIMI 4 and 5). Thrombosis In Myocardial Infarction.
Cannon CP; Sharis PJ; Schweiger MJ; McCabe CH; Diver DJ; Shah PK; Sequeira RF; Greene RM; Perritt RL; Poole WK; Braunwald E
Am J Cardiol; 1997 Sep; 80(6):696-9. PubMed ID: 9315571
[TBL] [Abstract][Full Text] [Related]
19. Early prognostic usefulness of C-reactive protein added to the Thrombolysis In Myocardial Infarction risk score in acute coronary syndromes.
Foussas SG; Zairis MN; Lyras AG; Patsourakos NG; Tsirimpis VG; Katsaros K; Beldekos DJ; Handanis SM; Mytas DZ; Karidis KS; Tselioti PG; Prekates AA; Ambrose JA
Am J Cardiol; 2005 Aug; 96(4):533-7. PubMed ID: 16098307
[TBL] [Abstract][Full Text] [Related]
20. Angiographic and clinical characteristics associated with the development of Q-wave and non-Q-wave myocardial infarction in the thrombolysis in myocardial infarction (TIMI) 14 trial.
Murphy SA; Dauterman K; de Lemos JA; Kermgard S; Antman EM; Braunwald E; Gibson CM;
Am Heart J; 2003 Jul; 146(1):42-7. PubMed ID: 12851606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
